
Syndromic Infectious Disease Diagnostics | BioFire Diagnostics
The BIOFIRE System is the new standard for syndromic infectious disease diagnostics. Simple, fast, and comprehensive, the BIOFIRE System delivers accurate results in about one hour.
FilmArray® Panels—Infectious Disease Diagnostics - BioFire
The BioFire ME Panel identifies the most common viral, bacterial, and yeast pathogens that cause infections in the central nervous system, which in some cases can be life-threatening.
Respiratory Pathogen Panel Test | BioFire Diagnostics
The BioFire® FilmArray® Panels combine several possible pathogens into one rapid test, with results in about an hour. BioFire’s multiplex PCR technology is more sensitive than culture and can help inform …
Point-of-Care Infectious Disease Testing | BioFire Diagnostics
It takes just one syndromic test, one small sample of synovial fluid, and about an hour to get results on 39 clinically relevant targets. The BioFire JI Panel is intended to be used in CLIA-moderate settings …
Technical Support & Resources | BioFire Diagnostics
Excellence in customer support is a value deeply ingrained in the culture of BioFire. We want to provide our customers with the information needed to use our products with confidence and get the most …
Setting New Standards in Molecular Diagnostics | BIOFIRE
BIOFIRE’s molecular solutions feature unmatched usability and speed, setting a new standard in molecular diagnostic platforms. The BIOFIRE ® FILMARRAY ® System and comprehensive panels …
ID Molecular Diagnostic Testing for Labs | BioFire Diagnostics
The BioFire System combines speed, ease of use, and a growing portfolio of comprehensive panels into one sample-to-answer system. BioFire offers a syndromic infectious disease testing approach that …
BioFire Blood Culture Identification (BCID) Panels | BioFire Diagnostics
The BioFire BCID2 Panel tests for 43 targets associated with bloodstream infections, including gram-negative bacteria, gram-positive bacteria, yeast, and 10 antimicrobial resistance genes—all with one …
Syndromic Testing: The Right Test, The First Time | BioFire Diagnostics
A BioFire syndromic test isolates, amplifies, and detects the DNA of microorganisms that cause overlapping signs and symptoms. The entire chemical process takes place inside a pouch, which has …
BioFire is Now bioMérieux | One Company. Endless Possibilities
BioFire was acquired in 2014 by bioMérieux SA, a global leader in in vitro diagnostics for more than 55 years. For several years BioFire continued to maintain its brand identity and operations.